Results 101 to 110 of about 255,660 (218)
Determining Parental Factors for Clinical Trial Attrition in Pediatric Acute Lymphoblastic Leukemia
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background/Objectives Despite high enrollment rates on Children's Oncology Group (COG) protocols, attrition after initial consent is challenging, introducing bias and prolonging trial completion. While adult oncology literature has identified predictors of withdrawal, little is known about caregiver decision‐making for child participation in ...
Kimberly L. Stathas +3 more
wiley +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Blinatumomab, a CD19xCD3 bispecific T‐cell engager, has become standard therapy for children with de novo B‐cell acute lymphoblastic leukemia (B‐ALL). This retrospective review describes the experience of blinatumomab administration in pediatric patients.
Julia M. Hurley +6 more
wiley +1 more source
South African scholars make Thomson Reuters ‘Highly Cited Researchers 2014’ (with corrigendum)
South African Journal of Science, 2015 Makia L. Diko
doaj +1 more source
Evaluate What Is Claimed to Be Confirmed: Initial Version of a Falsification Assessment Form (FAF)
MethodologyScientific claims, and the way they are tested, must be unambiguous and flexibility must be disclosed. Grounded in Popper’s principle of falsification, we suggest the Falsification Assessment Form (FAF).
Michael Höfler +9 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Together, leukemia and lymphoma account for 38.7% of newly diagnosed pediatric cancer cases in the United States each year. Many caregivers utilize online resources to inform medical health decisions. Understanding the readability of these materials is critical to ensuring comprehensible patient education.
Chloe Strege +6 more
wiley +1 more source
Scoping good papers for organizations' sustainability in management and engineering research
Frontiers in Sustainability, 2023 Tomohiko Sakao +14 more
doaj +1 more source
Acute Neurological Events in Children With Hemoglobin SC Disease: A Multicenter Retrospective Study
Pediatric Blood &Cancer, EarlyView.ABSTRACT Introduction Neurological manifestations in children with hemoglobin SC (HbSC) disease remain insufficiently characterized, particularly regarding acute events. The aim of this study was to describe the spectrum and frequency of acute neurological events in a multicenter cohort of children with HbSC disease.
Célia Paulmin +11 more
wiley +1 more source
Correction to: ‘How the pandemic affected psychological research’
Royal Society Open ScienceMario Gollwitzer +8 more
doaj +1 more source